Studies of CSF 5-HIAA in depression and suicidal behaviour.

[1]  M. Åsberg,et al.  Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls , 1981, Psychiatry Research.

[2]  M. Åsberg,et al.  Cortisol in the CSF of depressed and suicidal patients. , 1980, Archives of general psychiatry.

[3]  L. Oreland,et al.  Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behavior. , 1980, Progress in neuro-psychopharmacology.

[4]  M. Åsberg,et al.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression , 1979, Clinical pharmacology and therapeutics.

[5]  D. Murphy,et al.  Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid , 1979, Journal of neurochemistry.

[6]  W. Ganong,et al.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion. , 1978, Physiological reviews.

[7]  B. Johansson,et al.  A COMPARISON BETWEEN FLUOROMETRIC AND MASS FRAGMENTOGRAPHIC DETERMINATIONS OF HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN HUMAN CEREBROSPINAL FLUID , 1978, Journal of neurochemistry.

[8]  Grahame-Smith Dg,et al.  Processes regulating the functional activity of brain 5-hydroxytryptamine: results of animal experimentation and their relevance to the understanding and treatment of depression. , 1978 .

[9]  D. Murphy,et al.  The brain serotonergic system in the affective disorders. , 1978, Progress in neuro-psychopharmacology.

[10]  G. Sedvall,et al.  Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. , 1978, Communications in psychopharmacology.

[11]  M. Åsberg,et al.  On the role of plasma level monitoring of tricyclic antidepressants in clinical practice. , 1978, Communications in psychopharmacology.

[12]  G. Sedvall,et al.  Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients , 1977, Acta psychiatrica Scandinavica.

[13]  D. Murphy,et al.  Suicide attempts, platelet monoamine oxidase and the average evoked response , 1977, Acta psychiatrica Scandinavica.

[14]  M. Åsberg,et al.  Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine , 1977, Clinical pharmacology and therapeutics.

[15]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[16]  D. Murphy,et al.  The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. , 1976, Science.

[17]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[18]  J. Mendels,et al.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. , 1976, Archives of general psychiatry.

[19]  B. Winblad,et al.  LOWERED MONOAMINE OXIDASE ACTIVITY IN BRAINS FROM ALCOHOLIC SUICIDES , 1975, Journal of neurochemistry.

[20]  E. Anggard,et al.  Concentration gradients of monoamine metabolites in human cerebrospinal fluid. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[21]  E. Sachar.  Topics in psychoendocrinology , 1975 .

[22]  Hedley Aj.  Letter: Smoking and doctors. , 1973, Lancet.

[23]  L. Bertilsson,et al.  Determination of isomeric acid dopamine metabolites in human cerebrospinal fluid by mass fragmentography. , 1973, Life sciences.

[24]  M. Åsberg,et al.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline , 1973, Clinical pharmacology and therapeutics.

[25]  L. Bertilsson.  Quantitative determination of 4-hydroxy-3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentography. , 1973, Journal of chromatography.

[26]  G. Curzon.  Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders. , 1972, Journal of psychiatric research.

[27]  T. A. Kerr,et al.  Studies in the Classification of Affective Disorders , 1972, British Journal of Psychiatry.

[28]  T. A. Kerr,et al.  Studies in the Classification of Affective Disorders , 1972, British Journal of Psychiatry.

[29]  L. Bertilsson,et al.  Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry. , 1972, Analytical chemistry.

[30]  B. Johansson,et al.  Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. , 1971, Neuropharmacology.

[31]  D. Mcclure,et al.  Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. , 1971, Archives of general psychiatry.

[32]  G. Ashcroft,et al.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. , 1970, Brain : a journal of neurology.

[33]  W. Bunney,et al.  Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. , 1969, Archives of general psychiatry.

[34]  G. Oxenkrug,et al.  Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. , 1969, Lancet.

[35]  U. Malm,et al.  ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA , 1966, Journal of neurochemistry.

[36]  J. B. Stanton,et al.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.